Topic Hub
12 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 12 of 12 clinical reviews.
A clinician-reviewed guide to managing Lantus (insulin glargine) in geriatric patients during physical activity, community programs, and daily routines, with dosing cautions, hypoglycemia prevention, and ADA-aligned protocols.
Read clinical reviewA clinician-reviewed guide to managing Lantus (insulin glargine) in geriatric patients aged 65 and older, covering dose adjustments, hypoglycemia risks, monitoring protocols, and safe transition from pediatric or mixed-care settings into adult endocrinology.
Read clinical reviewComplete caregiver guide for administering Lantus (insulin glargine) to adults aged 65 and older: injection technique, hypoglycemia prevention, dose timing, storage, and when to call the care team.
Read clinical reviewA comprehensive clinical guide to off-label insulin glargine (Lantus) use in adolescents aged 12 to 17, covering dosing protocols, safety data, guideline recommendations, and comparisons with approved pediatric insulins.
Read clinical reviewA comprehensive clinical guide to how Lantus (insulin glargine) affects adults aged 65 and older, covering pharmacokinetics, hypoglycemia risk, dosing, and evidence-based management strategies for geriatric patients.
Read clinical reviewA clinician-reviewed guide to Lantus (insulin glargine) use in pediatric patients under age 12, covering glycemic control, neurodevelopmental effects, growth, hypoglycemia risk, and FDA-approved dosing guidance.
Read clinical reviewA clinically detailed review of off-label Lantus (insulin glargine) use in children under age 12, covering efficacy data, dosing, safety, and ADA guideline context for pediatric diabetes care.
Read clinical reviewA clinician-reviewed guide to transitioning children under 12 from pediatric to adult diabetes care when using Lantus (insulin glargine), covering dosing adjustments, provider handoffs, and what the evidence says.
Read clinical reviewA complete clinical guide to managing Lantus (insulin glargine) during school hours, sports, and extracurricular activities for teens ages 12 to 17, with dosing principles, hypoglycemia protocols, and educator communication tips.
Read clinical reviewA clinical deep-dive into how insulin glargine (Lantus) affects growth, pubertal development, bone health, and brain function in teens aged 12 to 17 with type 1 or type 2 diabetes.
Read clinical reviewA clinician-reviewed guide to managing Lantus (insulin glargine) in teens with type 1 or type 2 diabetes during the critical 12-to-25 age transition, covering dosing, A1C targets, care-team handoffs, and what to expect after the first adult endocrinology visit.
Read clinical reviewA clinical guide for parents, school nurses, and pediatric care teams on managing Lantus (insulin glargine) in children under 12 during school hours, sports, and daily activities. Includes dosing guidance, hypoglycemia protocols, and communication frameworks.
Read clinical review